1840P RNASEH2B loss and PARP inhibition (parpi) in metastatic castration resistant prostate cancer (mCRPC) (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.annonc.2023.09.2788
Publication URI: http://dx.doi.org/10.1016/j.annonc.2023.09.2788
Type: Journal Article/Review
Parent Publication: Annals of Oncology